Senior Scientist Drug Product Development at Johnson & Johnson (Leiden, The Netherlands). Expertise in late-stage product development (Tox to commercial) including formulation, characterization, and process development of viral, bioconjugate and protein-based vaccines. Led authoring and reviewing of drug product development sections of CMC dossier, Module 3 (BLA, MAA). Before joining Johnson & Johnson, worked at Baxter R&D Europe (Brussels, Belgium) in the late-stage development (lifecycle management) of advanced surgery products and renal solutions, and did two post-docs exploring ways to stabilize membrane proteins using amphipathic polymers - amphipols (Amsterdam, The Netherlands and Paris, France). PhD in Biophysical Chemistry, University of Groningen, The Netherlands. MSc in Biophysics, University of Belgrade, Serbia.